Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaRecruiting
NCT06091865Phase 3Updated Aug 20, 2026
Sponsor: Regeneron Pharmaceuticals
Diffuse Large B-cell Lymphoma (DLBCL)
United States, Australia, Austria, Belgium, Brazil +16 more
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersRecruiting
NCT04205968Phase 2Updated Aug 20, 2026
Sponsor: SWOG Cancer Research Network
Metastatic Small Intestinal Adenocarcinoma · Stage III Small Intestinal Adenocarcinoma AJCC v8 · Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 · Stage IIIB Small Intestinal Adenocarcinoma AJCC v8
United States
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsActive Not Recruiting
NCT04557449Phase 2Updated Aug 20, 2026
Sponsor: Pfizer
Liposarcoma · Prostate Cancer · Breast Neoplasms · Adenocarcinoma of Lung
United States, Argentina, China, Czechia, Japan +3 more
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic DysfunctionTerminated
NCT01065454Phase 2Updated Aug 20, 2026
Sponsor: Bayer
Hypertension, Pulmonary · Ventricular Dysfunction, Left
United States, Australia, Austria, Belgium, Canada +13 more
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastRecruiting
NCT06238622Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis · Progressive Pulmonary Fibrosis
United States, Argentina, Australia, Austria, Belgium +39 more
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or UbamatamabRecruiting
NCT04590326Phase 1, Phase 2Updated Aug 20, 2026
Sponsor: Regeneron Pharmaceuticals
Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer · Endometrial Cancer
United States, Belgium, Brazil, France, Spain
AI-Powered Artificial Vision for Visual ProsthesesEnrolling By Invitation
NCT06117332NAUpdated Aug 20, 2026
Sponsor: University of California, Santa Barbara
Blindness, Acquired
United States, Spain
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerRecruiting
NCT04329494Phase 1Updated Aug 20, 2026
Sponsor: City of Hope Medical Center
Clinical Stage IV Gastric Cancer AJCC v8 · Clinical Stage IVA Gastric Cancer AJCC v8 · Clinical Stage IVB Gastric Cancer AJCC v8 · Malignant Uterine Neoplasm
United States
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)Completed
NCT05915728Phase 3Updated Aug 20, 2026
Sponsor: Bayer
Contrast Enhancement in Magnetic Resonance Imaging · Non-central Nervous System Pathology
United States, Argentina, Bulgaria, Canada, China +11 more
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular DegenerationRecruiting
NCT07441642Phase 2Updated Aug 20, 2026
Sponsor: Novartis Pharmaceuticals
Geographic Atrophy Secondary to Age-related Macular Degeneration
United States, Australia, Bulgaria, Canada, Czechia +10 more
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)Recruiting
NCT05554406Phase 2Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy · Acute Myeloid Leukemia, Myelodysplasia-Related
United States, Canada, Puerto Rico
Targeted Realtime Assessment of Chronic Pain in YouthActive Not Recruiting
NCT06867757N/AUpdated Aug 20, 2026
Sponsor: Stanford University
Chronic Pain · Musculoskeletal Pain
United States
A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the KneeActive Not Recruiting
NCT03203330Phase 3Updated Aug 20, 2026
Sponsor: Kolon TissueGene, Inc.
Degenerative Osteoarthritis
United States
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)Recruiting
NCT07409181Phase 2Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Systemic Lupus Erythematosus
United States, Argentina, Australia, Brazil, Bulgaria +16 more
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesRecruiting
NCT07160244Phase 3Updated Aug 20, 2026
Sponsor: Pfizer
Healthy
United States, Argentina, Brazil, Canada, Finland +9 more
Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial CancerActive Not Recruiting
NCT03682068Phase 3Updated Aug 20, 2026
Sponsor: AstraZeneca
Unresectable Locally Advanced Urothelial Cancer · Metastatic Urothelial Cancer
United States, Argentina, Australia, Brazil, Bulgaria +17 more
A Study of MZE782 in Adults With PKURecruiting
NCT07694440Phase 2Updated Aug 20, 2026
Sponsor: Maze Therapeutics
Phenylketonuria (PKU)
United States
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)Recruiting
NCT07609940Phase 4Updated Aug 20, 2026
Sponsor: Regeneron Pharmaceuticals
Relapsed/Refractory Multiple Myeloma (RRMM)
United States
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield TrialsRecruiting
NCT05338697N/AUpdated Aug 20, 2026
Sponsor: Yale University
Stroke · Stroke, Acute · Stroke, Ischemic
United States
Biomarkers of Cervical Spondylotic MyelopathyNot Yet Recruiting
NCT07772297N/AUpdated Aug 20, 2026
Sponsor: University of California, San Francisco
Cervical Spondylotic Myelopathy
United States
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease ProgressionNot Yet Recruiting
NCT07540988Phase 3Updated Aug 20, 2026
Sponsor: Boehringer Ingelheim
Interstitial Lung Diseases
United States, Argentina, Austria, Belgium, Brazil +14 more
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineRecruiting
NCT07645924Phase 3Updated Aug 20, 2026
Sponsor: Kallyope Inc.
Migraine
United States
Antibiotic Cement Bead Pouch Versus Negative Pressure Wound TherapyRecruiting
NCT05615844Phase 3Updated Aug 20, 2026
Sponsor: University of Maryland, Baltimore
Open tíbia Fracture
United States, Canada
Fertilo In Vitro Research Study and TrialRecruiting
NCT06858111Phase 3Updated Aug 20, 2026
Sponsor: Gameto, Inc.
In Vitro Maturation of Oocytes
United States
Understanding New Cachexia Subtypes Through Observational Epidemiological ResearchRecruiting
NCT07776353N/AUpdated Aug 20, 2026
Sponsor: Kaiser Permanente
Advanced Colorectal Carcinoma · Advanced Lung Non-Small Cell Carcinoma · Advanced Pancreatic Adenocarcinoma · Stage IV Colorectal Cancer AJCC v8
United States

Previous page Next page